The Journal of Infectious Diseases最新文献

筛选
英文 中文
JC Polyomavirus Whole Genome Sequencing at the Single-Molecule Level Reveals Emerging Neurotropic Populations in Progressive Multifocal Leukoencephalopathy. JC多瘤病毒单分子水平全基因组测序揭示了进行性多灶性白质脑病中新出现的嗜神经人群。
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-28 DOI: 10.1093/infdis/jiab639
Anne Sophie L'Honneur, Juliana Pipoli Da Fonseca, Thomas Cokelaer, Flore Rozenberg
{"title":"JC Polyomavirus Whole Genome Sequencing at the Single-Molecule Level Reveals Emerging Neurotropic Populations in Progressive Multifocal Leukoencephalopathy.","authors":"Anne Sophie L'Honneur,&nbsp;Juliana Pipoli Da Fonseca,&nbsp;Thomas Cokelaer,&nbsp;Flore Rozenberg","doi":"10.1093/infdis/jiab639","DOIUrl":"https://doi.org/10.1093/infdis/jiab639","url":null,"abstract":"<p><strong>Background: </strong>JC polyomavirus (JCV) mostly causes asymptomatic persistent renal infections but may give rise in immunosuppressed patients to neurotropic variants that replicate in the brain, causing progressive multifocal leukoencephalopathy (PML). Rearrangements in the JCV genome regulator noncoding control region (NCCR) and missense mutations in the viral capsid VP1 gene differentiate neurotropic variants from virus excreted in urine.</p><p><strong>Methods: </strong>To investigate intrahost emergence of JCV neurotropic populations in PML, we deep sequenced JCV whole genome recovered from cerebrospinal fluid (CSF) and urine samples from 32 human immunodeficiency virus (HIV)-infected and non-HIV-infected PML patients at the single-molecule level.</p><p><strong>Results: </strong>JCV strains distributed among 6 of 7 known genotypes. Common patterns of NCCR rearrangements included an initial deletion mostly located in a short 10-nucleotide sequence, followed by duplications/insertions. Multiple NCCR variants present in individual CSF samples shared at least 1 rearrangement, suggesting they stemmed from a unique viral population. NCCR variants independently acquired single or double PML-specific adaptive VP1 mutations. NCCR variants recovered from urine and CSF displayed opposite deletion or duplication patterns in binding sites for transcription factors.</p><p><strong>Conclusions: </strong>Long-read deep sequencing shed light on emergence of neurotropic JCV populations in PML.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1151-1161"},"PeriodicalIF":6.4,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39870922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection. 对SARS-CoV-2感染的纵向全身和粘膜免疫反应
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-28 DOI: 10.1093/infdis/jiac065
Peter F Wright, Alejandra C Prevost-Reilly, Harini Natarajan, Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, Anna S Miele, Joshua A Weiner, Robert D Nerenz, Margaret E Ackerman
{"title":"Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection.","authors":"Peter F Wright,&nbsp;Alejandra C Prevost-Reilly,&nbsp;Harini Natarajan,&nbsp;Elizabeth B Brickley,&nbsp;Ruth I Connor,&nbsp;Wendy F Wieland-Alter,&nbsp;Anna S Miele,&nbsp;Joshua A Weiner,&nbsp;Robert D Nerenz,&nbsp;Margaret E Ackerman","doi":"10.1093/infdis/jiac065","DOIUrl":"https://doi.org/10.1093/infdis/jiac065","url":null,"abstract":"<p><strong>Background: </strong>A longitudinal study was performed to determine the breadth, kinetics, and correlations of systemic and mucosal antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.</p><p><strong>Methods: </strong>Twenty-six unvaccinated adults with confirmed coronavirus disease 2019 (COVID-19) were followed for 6 months with 3 collections of blood, nasal secretions, and stool. Control samples were obtained from 16 unvaccinated uninfected individuals. SARS-CoV-2 neutralizing and binding antibody responses were respectively evaluated by pseudovirus assays and multiplex bead arrays.</p><p><strong>Results: </strong>Neutralizing antibody responses to SARS-CoV-2 were detected in serum and respiratory samples for 96% (25/26) and 54% (14/26), respectively, of infected participants. Robust binding antibody responses against SARS-CoV-2 spike protein and S1, S2, and receptor binding (RBD) domains occurred in serum and respiratory nasal secretions, but not in stool samples. Serum neutralization correlated with RBD-specific immunoglobulin (Ig)G, IgM, and IgA in serum (Spearman ρ = 0.74, 0.66, and 0.57, respectively), RBD-specific IgG in respiratory secretions (ρ = 0.52), disease severity (ρ = 0.59), and age (ρ = 0.40). Respiratory mucosal neutralization correlated with RBD-specific IgM (ρ = 0.42) and IgA (ρ = 0.63).</p><p><strong>Conclusions: </strong>Sustained antibody responses occurred after SARS-CoV-2 infection. Notably, there was independent induction of IgM and IgA binding antibody and neutralizing responses in systemic and respiratory compartments. These observations have implications for current vaccine strategies and understanding SARS-CoV-2 reinfection and transmission.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1204-1214"},"PeriodicalIF":6.4,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/46/jiac065.PMC8903457.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39941439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Why Does Zika Virus Persist in the Semen of Some Men But Not Others? 为什么寨卡病毒在一些男性精液中存在,而在另一些男性精液中不存在?
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-28 DOI: 10.1093/infdis/jiac330
Andrew D Haddow
{"title":"Why Does Zika Virus Persist in the Semen of Some Men But Not Others?","authors":"Andrew D Haddow","doi":"10.1093/infdis/jiac330","DOIUrl":"https://doi.org/10.1093/infdis/jiac330","url":null,"abstract":"","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1125-1126"},"PeriodicalIF":6.4,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40669738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery. 儿童多系统炎症综合征患者冠状病毒2抗原特异性全身免疫反应增强及康复后逆转
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-28 DOI: 10.1093/infdis/jiac304
Nathella Pavan Kumar, Aishwarya Venkataraman, Arul Nancy, Kadar Moideen, Poovazhagi Varadarjan, Elilarasi Selladurai, Thankgavelu Sangaralingam, Ramya Selvam, Akshith Thimmaiah, Suresh Natarajan, Ganesh Ramasamy, Syed Hissar, Umadevi Radayam Ranganathan, Subash Babu
{"title":"Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.","authors":"Nathella Pavan Kumar,&nbsp;Aishwarya Venkataraman,&nbsp;Arul Nancy,&nbsp;Kadar Moideen,&nbsp;Poovazhagi Varadarjan,&nbsp;Elilarasi Selladurai,&nbsp;Thankgavelu Sangaralingam,&nbsp;Ramya Selvam,&nbsp;Akshith Thimmaiah,&nbsp;Suresh Natarajan,&nbsp;Ganesh Ramasamy,&nbsp;Syed Hissar,&nbsp;Umadevi Radayam Ranganathan,&nbsp;Subash Babu","doi":"10.1093/infdis/jiac304","DOIUrl":"https://doi.org/10.1093/infdis/jiac304","url":null,"abstract":"<p><strong>Background: </strong>Multisystem inflammatory syndrome in children (MIS-C) presents with inflammation and pathology of multiple organs in the pediatric population in the weeks following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.</p><p><strong>Methods: </strong>We characterized the SARS-CoV-2 antigen-specific cytokine and chemokine responses in children with MIS-C, coronavirus disease 2019 (COVID-19), and other infectious diseases.</p><p><strong>Results: </strong>MIS-C is characterized by elevated levels of type 1 (interferon-γ, interleukin [IL] 2), type 2 (IL-4, IL-13), type 17 (IL-17), and other proinflammatory cytokines (IL-1α, IL-6, IL-12p70, IL-18, and granulocyte-macrophage colony-stimulating factor) in comparison to COVID-19 and other infectious diseases following stimulation with SARS-CoV-2-specific antigens. Similarly, upon SARS-CoV-2 antigen stimulation, CCL2, CCL3, and CXCL10 chemokines were significantly elevated in children with MIS-C in comparison to the other 2 groups. Principal component analysis based on these cytokines and chemokines could clearly distinguish MIS-C from both COVID-19 and other infections. In addition, these responses were significantly diminished and normalized 6-9 months after recovery.</p><p><strong>Conclusions: </strong>Our data suggest that MIS-C is characterized by an enhanced production of cytokines and chemokines that may be associated with disease pathogenesis.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1215-1223"},"PeriodicalIF":6.4,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384631/pdf/jiac304.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40684726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Duration of Humoral Immunity and Cross-Neutralizing Activity Against the Alpha, Beta, and Delta Variants After Wild-Type Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Prospective Cohort Study. 野生型严重急性呼吸综合征冠状病毒2型感染后体液免疫持续时间和对α、β和δ变异的交叉中和活性:一项前瞻性队列研究
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-21 DOI: 10.1093/infdis/jiac050
Ji Yun Noh, Jeong Sun Yang, Soon Young Hwang, Hakjun Hyun, Hye Seong, Jin Gu Yoon, Soo Young Yoon, Hee Jin Cheong, Woo Joo Kim, Woo Jung Park, Jun Won Kim, Joo Yeon Lee, Joon Young Song
{"title":"Duration of Humoral Immunity and Cross-Neutralizing Activity Against the Alpha, Beta, and Delta Variants After Wild-Type Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Prospective Cohort Study.","authors":"Ji Yun Noh,&nbsp;Jeong Sun Yang,&nbsp;Soon Young Hwang,&nbsp;Hakjun Hyun,&nbsp;Hye Seong,&nbsp;Jin Gu Yoon,&nbsp;Soo Young Yoon,&nbsp;Hee Jin Cheong,&nbsp;Woo Joo Kim,&nbsp;Woo Jung Park,&nbsp;Jun Won Kim,&nbsp;Joo Yeon Lee,&nbsp;Joon Young Song","doi":"10.1093/infdis/jiac050","DOIUrl":"https://doi.org/10.1093/infdis/jiac050","url":null,"abstract":"<p><p>A prospective cohort study was conducted for adults with a diagnosis of with coronavirus disease 2019 (COVID-19). Convalescent blood samples were obtained 4, 6, and 11 months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The seropositivity of anti-spike antibody was maintained in all patients (100%) until 11 months after COVID-19 diagnosis. Neutralizing antibody levels against wild-type SARS-CoV-2 gradually decreased but remained positive in >50% of patients 11 months after diagnosis: in 98.5% (67 of 68) at 4 months, 86.8% (46 of 53) at 6 months, and 58.8% (40 of 68) at 11 months. However, cross-neutralizing activity against the Beta and Delta variants was attenuated 2.53-fold and 2.93-fold, respectively, compared with the wild-type strain.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"975-978"},"PeriodicalIF":6.4,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903377/pdf/jiac050.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39929479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Predictors of Hospitalization and Superinfection in Viral Respiratory Tract Infections Between Influenza and Paramyxoviruses: The SUPERFLUOUS Study. 流感和副粘病毒之间病毒性呼吸道感染住院和重复感染的预测因素:多余的研究。
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-21 DOI: 10.1093/infdis/jiab525
Benoit Lemarie, Ghilas Boussaid, Elyanne Gault, Helene Prigent, Sebastien Beaune, Frederique Moreau, Jennifer Dumoulin, Marion Pepin, Segolene Greffe, Pierre De Truchis, Benjamin Davido
{"title":"Predictors of Hospitalization and Superinfection in Viral Respiratory Tract Infections Between Influenza and Paramyxoviruses: The SUPERFLUOUS Study.","authors":"Benoit Lemarie,&nbsp;Ghilas Boussaid,&nbsp;Elyanne Gault,&nbsp;Helene Prigent,&nbsp;Sebastien Beaune,&nbsp;Frederique Moreau,&nbsp;Jennifer Dumoulin,&nbsp;Marion Pepin,&nbsp;Segolene Greffe,&nbsp;Pierre De Truchis,&nbsp;Benjamin Davido","doi":"10.1093/infdis/jiab525","DOIUrl":"https://doi.org/10.1093/infdis/jiab525","url":null,"abstract":"<p><strong>Background: </strong>Viral respiratory tract infections (VRTIs) are among the most common diseases, but the risks of superinfection for different virus species have never been compared.</p><p><strong>Methods: </strong>Multicenter retrospective study conducted among adults who tested positive for VRTIs with reverse-transcription polymerase chain reaction. We compared characteristics between influenza (A or B) and paramyxoviruses (respiratory syncytial virus, parainfluenza virus types 1 and 3, and human metapneumovirus) and identified predictors of superinfection and hospitalization.s.</p><p><strong>Results: </strong>Five hundred ninety patients had VRTI, including 347 (59%) influenza and 243 paramyxovirus infections with comparable rates of superinfections (53% vs 60%). In multivariate analyses, the predictors of superinfections were age >75 years (adjusted odds ratio, 2.37 [95% confidence interval, 1.65-3.40]), chronic respiratory disease (1.79 [1.20-2.67]), and biological abnormalities, including neutrophil count >7000/µL (1.98 [1.34-2.91)], eosinophil count <50/µL (2.53 [1.61-3.98], and procalcitonin level >0.25ng/mL (2.8 [1.65-4.73]). The predictors of hospitalization were age >75 years old (adjusted odds ratio, 3.49 [95% confidence interval, 2.17-5.63]), paramyxovirus infection (2.28 [1.39-3.75]), long-term use of inhaled corticosteroids (2.49 [1.13-5.49]), and biological abnormalities, including neutrophil count >7000/µL (2.38 [1.37-4.12)] and procalcitonin level >0.25ng/mL (2.49 [1.23-5.02]). Kaplan-Meier survival curves showed that influenza-infected patients had a higher mortality rate than those with paramyxovirus infections (8.9% vs 4.5%, respectively; P = .02).</p><p><strong>Conclusions: </strong>Our study revealed a high rate of superinfection (56%), not related to viral species. However influenza virus was associated with a poorer prognosis than paramyxoviruses, pleading for a broader and large-scale vaccination of individual at risk of VRTIs.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1027-1035"},"PeriodicalIF":6.4,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39508815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Quantification of Viral RNA in Multiple Pieces of Explant Liver Tissue Shows Distinct Focal Differences in Hepatitis B Infection. 多块外植肝组织中病毒RNA的定量显示乙型肝炎感染的明显局灶差异。
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-21 DOI: 10.1093/infdis/jiab469
Gustaf E Rydell, Kasthuri Prakash, Simon B Larsson, Catarina Skoglund, Johan Ringlander, Maria E Andersson, Maria Castedal, Heléne Norder, Magnus Lindh
{"title":"Quantification of Viral RNA in Multiple Pieces of Explant Liver Tissue Shows Distinct Focal Differences in Hepatitis B Infection.","authors":"Gustaf E Rydell,&nbsp;Kasthuri Prakash,&nbsp;Simon B Larsson,&nbsp;Catarina Skoglund,&nbsp;Johan Ringlander,&nbsp;Maria E Andersson,&nbsp;Maria Castedal,&nbsp;Heléne Norder,&nbsp;Magnus Lindh","doi":"10.1093/infdis/jiab469","DOIUrl":"https://doi.org/10.1093/infdis/jiab469","url":null,"abstract":"<p><p>Hepatitis B virus (HBV) DNA and RNA were quantified by digital PCR assays in 20-30 tissue pieces from each of 4 liver explants with cirrhosis caused by HBV. The within-patient variability of HBV RNA levels between pieces was up to a 1000-fold. Core RNA and S RNA levels were similar and correlated strongly when replication was high, supporting that transcription was from covalently closed circular DNA (cccDNA). By contrast, enhanced expression of S RNA relative to cccDNA and core RNA in patients with medium-high or low replication supports that HBV surface antigen (HBsAg) can be expressed mainly from integrated HBV DNA in such patients.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1036-1040"},"PeriodicalIF":6.4,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/41/jiab469.PMC9492311.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39426909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Trends in Rotavirus Laboratory Detections and Internet Search Volume Before and After Rotavirus Vaccine Introduction and in the Context of the Coronavirus Disease 2019 Pandemic-United States, 2000-2021. 轮状病毒疫苗引入前后和2019冠状病毒大流行背景下的轮状病毒实验室检测和互联网搜索量趋势——美国,2000-2021
The Journal of Infectious Diseases Pub Date : 2022-09-21 DOI: 10.1093/infdis/jiac062
Eleanor Burnett, Umesh D Parashar, Amber Winn, Jacqueline E Tate
{"title":"Trends in Rotavirus Laboratory Detections and Internet Search Volume Before and After Rotavirus Vaccine Introduction and in the Context of the Coronavirus Disease 2019 Pandemic-United States, 2000-2021.","authors":"Eleanor Burnett, Umesh D Parashar, Amber Winn, Jacqueline E Tate","doi":"10.1093/infdis/jiac062","DOIUrl":"10.1093/infdis/jiac062","url":null,"abstract":"<p><strong>Background: </strong>Since rotavirus vaccines became available in the United States in 2006, there have been reductions in rotavirus hospitalizations, changes in seasonality, and the emergence of a biennial trend of rotavirus activity. Reductions in other pathogens have been associated with coronavirus disease 2019 (COVID-19) mitigation measures. We assessed ongoing rotavirus disease trends during the COVID-19 pandemic.</p><p><strong>Methods: </strong>We report a 3-week moving average of the number of rotavirus tests, positive tests, and the percent positivity from laboratories reporting to the National Respiratory and Enteric Virus Surveillance System (NREVSS) from July 2000 through June 2021. To complement NREVSS data, we analyzed Google internet search interest in \"rotavirus\" from July 2004 to June 2021.</p><p><strong>Results: </strong>Declines in rotavirus activity following vaccine introduction and the biennial trend are evident through the 2018-2019 surveillance year. In 2019-2021, rotavirus test positivity was below the historic ranges during the months of typically high rotavirus activity, and precipitous declines were noted in March 2020.</p><p><strong>Conclusions: </strong>In the 15 years since rotavirus vaccine was introduced, the number of laboratory-detected rotavirus infections has been consistently lower than during the prevaccine era. During the COVID-19 pandemic, rotavirus activity was suppressed. There may be many rotavirus-susceptible children during the 2021-2022 rotavirus season.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"967-974"},"PeriodicalIF":0.0,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383438/pdf/jiac062.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39937296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Inactivated Vaccination on Humoral Immune Responses in Patients Infected With Delta or Omicron Variants. 灭活疫苗对三角洲或组粒变异感染患者体液免疫反应的影响。
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-21 DOI: 10.1093/infdis/jiac274
Zhigang Ren, Ranran Sun, Guangying Cui, Haiyu Wang, Donghua Zhang, Juan Li, Yong Zhang, Zujiang Yu
{"title":"Effects of Inactivated Vaccination on Humoral Immune Responses in Patients Infected With Delta or Omicron Variants.","authors":"Zhigang Ren,&nbsp;Ranran Sun,&nbsp;Guangying Cui,&nbsp;Haiyu Wang,&nbsp;Donghua Zhang,&nbsp;Juan Li,&nbsp;Yong Zhang,&nbsp;Zujiang Yu","doi":"10.1093/infdis/jiac274","DOIUrl":"https://doi.org/10.1093/infdis/jiac274","url":null,"abstract":"","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1120-1122"},"PeriodicalIF":6.4,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40471178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review. 使用即时检测或干血点样本检测丙型肝炎病毒RNA的诊断准确性:系统评价
IF 6.4
The Journal of Infectious Diseases Pub Date : 2022-09-21 DOI: 10.1093/infdis/jiac049
Beth Catlett, Behzad Hajarizadeh, Evan Cunningham, Brett Wolfson-Stofko, Alice Wheeler, Benazir Khandaker-Hussain, Jordan J Feld, Elisa Martró, Stéphane Chevaliez, Jean Michel Pawlotsky, Chrianna Bharat, Philip H Cunningham, Gregory J Dore, Tanya Applegate, Jason Grebely
{"title":"Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review.","authors":"Beth Catlett,&nbsp;Behzad Hajarizadeh,&nbsp;Evan Cunningham,&nbsp;Brett Wolfson-Stofko,&nbsp;Alice Wheeler,&nbsp;Benazir Khandaker-Hussain,&nbsp;Jordan J Feld,&nbsp;Elisa Martró,&nbsp;Stéphane Chevaliez,&nbsp;Jean Michel Pawlotsky,&nbsp;Chrianna Bharat,&nbsp;Philip H Cunningham,&nbsp;Gregory J Dore,&nbsp;Tanya Applegate,&nbsp;Jason Grebely","doi":"10.1093/infdis/jiac049","DOIUrl":"https://doi.org/10.1093/infdis/jiac049","url":null,"abstract":"<p><strong>Background: </strong>Finger-stick point-of-care and dried blood spot (DBS) hepatitis C virus (HCV) RNA testing increases testing uptake and linkage to care. This systematic review evaluated the diagnostic accuracy of point-of-care testing and DBS to detect HCV RNA.</p><p><strong>Methods: </strong>Bibliographic databases and conference presentations were searched for eligible studies. Meta-analysis was used to pool estimates.</p><p><strong>Results: </strong>Of 359 articles identified, 43 studies were eligible and included. When comparing the Xpert HCV Viral Load Fingerstick assay to venous blood samples (7 studies with 987 samples), the sensitivity and specificity for HCV RNA detection was 99% (95% confidence interval [CI], 97%-99%) and 99% (95% CI, 94%-100%) and for HCV RNA quantification was 100% (95% CI, 93%-100%) and 100% (95% CI, 94%-100%). The proportion of invalid results following Xpert HCV Viral Load Fingerstick testing was 6% (95% CI, 3%-11%). When comparing DBS to venous blood samples (28 studies with 3988 samples) the sensitivity and specificity for HCV RNA detection was 97% (95% CI, 95%-98%) and 100% (95% CI, 98%-100%) and for HCV RNA quantification was 98% (95% CI, 96%-99%) and 100% (95% CI, 95%-100%).</p><p><strong>Conclusions: </strong>Excellent diagnostic accuracy was observed across assays for detection of HCV RNA from finger-stick and DBS samples. The proportion of invalid results following Xpert HCV Viral Load Fingerstick testing highlights the importance of operator training and quality assurance programs.</p>","PeriodicalId":509652,"journal":{"name":"The Journal of Infectious Diseases","volume":" ","pages":"1005-1021"},"PeriodicalIF":6.4,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39773592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信